業績

{ 80件 }

Sekizaki T, Kameda H, Nomoto H,Cho KY, Nakamura A, Takahashi K, Miyoshi A, Wada N, Takeuchi J, Nagai S, Miyoshi H, Atsumi T Dipeptidyl peptidase-4 inhibitor may exacerbate Graves disease: a multicenter observational study J Diabetes Investig, in press.

IF: 3.761

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Yamauchi Y, Kameda H, Omori K, Tani M, Cho KY, Nakamura A, Miyoshi H,Tanaka S, Atsumi T.

Severe infection including disseminated herpes zoster triggered by subclinical Cushings disease: a case report BMC endocrine disorders, in press

IF:1.994

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Aika Miya, Akinobu Nakamura, Takahisa Handa, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Yoichi M. Ito, Hideaki Miyoshi, Tatsuya Atsumi Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring Scientific Reports, in press.

IF: 3.998

Aika Miya, Akinobu Nakamura, Takahisa Handa, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Yoichi M. Ito, Hideaki Miyoshi, Tatsuya Atsumi Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring Scientific Reports, in press.

IF: 3.998 

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Handa T, Nakamura A, Miya A, Nomoto H, Kameda H, Cho KY, Nagai S, Yoshioka N, Miyoshi H, Atsumi T. The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study.

Diabetol Metab Syndr, in press.

IF: 2.361 

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Miyoshi H, Baxter M, Kimura T, Hattori M, Morimoto Y, Marinkovich D, Tamiwa M, Hirose T. A real-world, observational study of the initiation, use, and effectiveness of basal-bolus or premixed insulin in Japanese people with type 2 diabetes. Diabetes Ther. 2021, in press IF: 3.179
  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Tsuchida K, Nakamura A, Miyoshi H, Yang K, Yamauchi Y, Kawata S, Omori K, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Seino Y, Terauchi Y, Atsumi T. Glucokinase is required for high-starch diet-induced beta cell mass expansion in mice. J Diabetes Investig, in press. IF: 3.761
  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Shimatsu A, Nakamura A, Takahashi Y, Fujio S, Satoh F, Tahara S, Nishioka H, Takano K, Yamashita M, Arima H, Tominaga A, Tateishi S, Matsushita Y. Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: A multicenter, single-arm, phase 3 study in Japan. Endocr J, in press. IF: 1.952
  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Omori Kazuno, Tsuchida K, Miya A, Shigesawa I, Tsuchida K, Yanagiya S, Kameda H, Yokoyama H, Taneda S, Kurihara Y, Aoki S, Nishimoto N, Atsumi T, Miyoshi H.

Improved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin: Secondary Analyses of the CALMER study.

Journal of Diabetes Investigation, in press

IF: 3.761 

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Nomoto H, Oba-Yamamoto C, Takahashi Y, Takeuchi J, Nagai S, Yokoyama H, Taneda S, Kurihara Y, Aoki S, Kameda H, Cho KY, Nakamura A, Atsumi T, Miyoshi H. Effects of switching from liraglutide or dulaglutide to subcutaneous semaglutide on glucose metabolism and treatment satisfaction in patients with type 2 diabetes: protocol for a multi-center, prospective, randomized, open-label, blinded endpoint parallel-group comparison study (the SWITCH-SEMA 1 study). Diabetes Ther. 2020, in press IF: 3.179
  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Kimura Y, Higuchi I, Kobayashi M, Furugen A, Narumi K, Suzuki Y, Miyoshi H, Nakamura A, Atsumi T, Iseki K. The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes. Drug Metab Pharmacokinet, in press. IF: 2.772
  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著